Skip to main
VRDN
VRDN

Viridian Therapeutics (VRDN) Earnings Dates & Reports

Viridian Therapeutics (VRDN) Most Recent Earnings

Report DateAug 6, 2025
Period EndingQ2 2025
Est. EPS-$0.98
Actual EPS-$1
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Viridian Therapeutics (VRDN) Earnings per Share (EPS) History

Signup for full access
Browse free

Viridian Therapeutics (VRDN) Latest Earnings

The value each VRDN share was expected to gain vs. the value each share gained.

Viridian Therapeutics (VRDN) reported its most recent earnings on Aug 6, 2025 for Q2 2025, posting earnings per share (EPS) of -$1. This exceeded analysts' expectations of -$0.98 by 2.04%, marking a Miss.

For comparison, Viridian Therapeutics reported EPS of -$1.02 in the same quarter last year.

The company is expected to announce its next earnings report on 11/11/2025, with analysts projecting an EPS of -$0.88.

Viridian Therapeutics (VRDN) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Nov 11, 2025
-$0.88Next earnings call Nov. 11, 2025
Q2 2025Aug 6, 2025
-$0.98-$1.00+2.04%
Q1 2025May 6, 2025
-$0.96-$0.87-9.37%
Q4 2024Feb 27, 2025
-$1.00-$0.81-19.00%
Q3 2024Nov 12, 2024
-$1.05-$1.15+9.52%

Viridian Therapeutics (VRDN) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Viridian Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 6, 2025
May 6, 2025
Feb 27, 2025
Nov 12, 2024

Viridian Therapeutics (VRDN) Earnings FAQs

Viridian Therapeutics (VRDN) last reported earnings on Aug 6, 2025 for Q2 2025, posting an EPS of -$1, which Miss the estimate of -$0.98 by 2.04%.

For Q2 2025, Viridian Therapeutics (VRDN) reported an EPS of -$1, missing analysts' estimate of -$0.98 by 2.04%.

For Q2 2025, Viridian Therapeutics (VRDN) Miss expectations with an actual EPS of -$1 vs. an estimated EPS of -$0.98.

Following the last earnings report on Aug 6, 2025, Viridian Therapeutics (VRDN)'s stock price moved — from — to —.

The next Viridian Therapeutics (VRDN) earnings call is scheduled for Nov. 11, 2025, where executives will discuss financial results and outlook.

Viridian Therapeutics (VRDN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.